These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 26685718)
1. Propranolol versus captopril in the treatment of infantile hemangioma (IH): A randomized controlled trial. Zaher H; Rasheed H; El-Komy MM; Hegazy RA; Gawdat HI; Abdel Halim DM; Abdel Hay RM; Hegazy RA; Mohy AM J Am Acad Dermatol; 2016 Mar; 74(3):499-505. PubMed ID: 26685718 [TBL] [Abstract][Full Text] [Related]
2. Serum levels of renin, angiotensin-converting enzyme and angiotensin II in patients treated by surgical excision, propranolol and captopril for problematic proliferating infantile haemangioma. Sulzberger L; Baillie R; Itinteang T; de Jong S; Marsh R; Leadbitter P; Tan ST J Plast Reconstr Aesthet Surg; 2016 Mar; 69(3):381-6. PubMed ID: 26612192 [TBL] [Abstract][Full Text] [Related]
3. Treatment of infantile haemangioma with captopril. Tan ST; Itinteang T; Day DJ; O'Donnell C; Mathy JA; Leadbitter P Br J Dermatol; 2012 Sep; 167(3):619-24. PubMed ID: 22533490 [TBL] [Abstract][Full Text] [Related]
4. Effect of captopril on infantile haemangiomas: a retrospective case series. Christou EM; Wargon O Australas J Dermatol; 2012 Aug; 53(3):216-8. PubMed ID: 22671578 [TBL] [Abstract][Full Text] [Related]
5. β-blocker therapy for infantile hemangioma. Koh SP; Leadbitter P; Smithers F; Tan ST Expert Rev Clin Pharmacol; 2020 Aug; 13(8):899-915. PubMed ID: 32662682 [TBL] [Abstract][Full Text] [Related]
6. The expression of renin-angiotensin-aldosterone axis components in infantile hemangioma tissue and the impact of propranolol treatment. Dornhoffer JR; Wei T; Zhang H; Miller E; A Cleves M; Richter GT Pediatr Res; 2017 Jul; 82(1):155-163. PubMed ID: 28376078 [TBL] [Abstract][Full Text] [Related]
8. [Infantile hemangioma and propranolol: a therapeutic "revolution". Literature review]. Yilmaz L; Dangoisse C; Semaille P Rev Med Brux; 2013; 34(6):479-84. PubMed ID: 24505868 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases. Sagi L; Zvulunov A; Lapidoth M; Ben Amitai D Dermatology; 2014; 228(2):136-44. PubMed ID: 24556822 [TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of VEGF and bFGF in the course of propranolol therapy of infantile hemangioma in children: Are we closer to understand the mechanism of action of propranolol on hemangiomas? Babiak-Choroszczak L; Giżewska-Kacprzak K; Gawrych E; Fischer K; Walecka A; Puchalska-Niedbał L; Rajewska-Majchrzak J; Bagłaj M Adv Clin Exp Med; 2018 May; 27(5):703-710. PubMed ID: 29790692 [TBL] [Abstract][Full Text] [Related]
11. Clinical features of cutaneous infantile hemangioma combined with asymptomatic infantile hepatic hemangioma and efficacy of propranolol treatment. Li L; Yu L; Xu Z; Wei L; Zhang B; Han X; Sun Y; Ma L J Cosmet Dermatol; 2023 Dec; 22(12):3369-3374. PubMed ID: 37313653 [TBL] [Abstract][Full Text] [Related]
12. The role of propranolol in the treatment of infantile hemangioma. Laranjo S; Costa G; Paramés F; Freitas I; Martins JD; Trigo C; Pinto FF Rev Port Cardiol; 2014 May; 33(5):289-95. PubMed ID: 24906291 [TBL] [Abstract][Full Text] [Related]
13. Serum-level changes of vascular endothelial growth factor in children with infantile hemangioma after oral propranolol therapy. Chen XD; Ma G; Huang JL; Chen H; Jin YB; Ye XX; Hu XJ; Lin XX Pediatr Dermatol; 2013; 30(5):549-53. PubMed ID: 23909679 [TBL] [Abstract][Full Text] [Related]
14. Low-dose propranolol for multiple hepatic and cutaneous hemangiomas with deranged liver function. Tan ST; Itinteang T; Leadbitter P Pediatrics; 2011 Mar; 127(3):e772-6. PubMed ID: 21357335 [TBL] [Abstract][Full Text] [Related]
15. Serum and tissue profile of VEGF and its receptors VGFR1/R2 in children with infantile hemangiomas on systemic propranolol treatment. Przewratil P; Kobos J; Wnęk A; Szemraj J; Wyrzykowski D; Chrzanowska B; Andrzejewska E; Taran K Immunol Lett; 2016 Jul; 175():44-9. PubMed ID: 27178307 [TBL] [Abstract][Full Text] [Related]
16. Propranolol treatment of infantile hemangioma is not associated with psychological problems at 7 years of age. Moyakine AV; Spillekom-van Koulil S; van der Vleuten CJM J Am Acad Dermatol; 2017 Jul; 77(1):105-108. PubMed ID: 28190620 [TBL] [Abstract][Full Text] [Related]
17. Infantile hemangioma: pathogenesis and mechanisms of action of propranolol. Rotter A; de Oliveira ZNP J Dtsch Dermatol Ges; 2017 Dec; 15(12):1185-1190. PubMed ID: 29193649 [TBL] [Abstract][Full Text] [Related]
18. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned? Erman A; Boner G; van Dijk DJ J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825 [TBL] [Abstract][Full Text] [Related]
19. Use of the Hemangioma Severity Scale to facilitate treatment decisions for infantile hemangiomas. Moyakine AV; Herwegen B; van der Vleuten CJM J Am Acad Dermatol; 2017 Nov; 77(5):868-873. PubMed ID: 28818436 [TBL] [Abstract][Full Text] [Related]
20. Retrospective study of the treatment of infantile hemangiomas using a combination of propranolol and pulsed dye laser. Reddy KK; Blei F; Brauer JA; Waner M; Anolik R; Bernstein L; Brightman L; Hale E; Karen J; Weiss E; Geronemus RG Dermatol Surg; 2013 Jun; 39(6):923-33. PubMed ID: 23458381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]